These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 206118)

  • 1. Age-related changes in the binding of 3H-dihydroalprenolol in rat brain [proceedings].
    Greenberg LH; Dix RK; Weiss B
    Adv Exp Med Biol; 1978; 97():245-9. PubMed ID: 206118
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of (-)-[3H]-dihydroalprenolol binding to beta-adrenoceptors on rat lung membranes [proceedings].
    Barnett DB; Nahorski SR; Rugg EL
    Br J Pharmacol; 1977 Nov; 61(3):459P. PubMed ID: 201324
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations of [3H]dihydroalprenolol with biological membranes.
    Mendel CM; Almon RR
    Gen Pharmacol; 1979; 10(1):31-40. PubMed ID: 33101
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 3H-dihydroalprenolol binding to beta-adrenergic receptors of rat brain: two binding sites of racemic propranolol in displacement experiments.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2979-84. PubMed ID: 2824078
    [No Abstract]   [Full Text] [Related]  

  • 7. Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.
    Dolphin A; Adrien J; Hamon M; Bockaert J
    Mol Pharmacol; 1979 Jan; 15(1):1-15. PubMed ID: 218089
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-adrenergic receptors in brown adipose tissue: identification by (-)[3H]dihydroalprenolol binding.
    Bukowiecki LJ; Caron MG; Vallieres J; LeBlanc J
    Experientia Suppl; 1978; 32():55-9. PubMed ID: 206459
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of lectins.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 Jun; 38(2):121-5. PubMed ID: 2993717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls in the assessment of the specific binding of(-)[3H]-dihydroalprenolol to beta-adrenoceptors [proceedings].
    Nahorski SR; Richardson A
    Br J Pharmacol; 1979 Jul; 66(3):469P-470P. PubMed ID: 230879
    [No Abstract]   [Full Text] [Related]  

  • 11. beta-Adrenergic receptors in aged rat brain: reduced number and capacity of pineal gland to develop supersensitivity.
    Greenberg LH; Weiss B
    Science; 1978 Jul; 201(4350):61-3. PubMed ID: 208145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of fluorescent and radiolabelled alprenolol to intact cultured brain cells and liposomes.
    Maderspach K; Nemecz G; Yigiter M
    Acta Biol Acad Sci Hung; 1981; 32(3-4):283-90. PubMed ID: 6291288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of polymeric effectors on binding of 3H-dihydroalprenolol to beta-adrenergic receptor of rat brain.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 May; 38(1):17-23. PubMed ID: 2991640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Separation of [3H]dihydroalprenolol, free or bound to solubilized beta-adrenergic receptors, on a cation-exchange resin].
    Voeĭkov VL; Gurevich VV
    Bioorg Khim; 1983 May; 9(5):628-32. PubMed ID: 6091694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interindividual changes in the specific binding of 3H-dihydroalprenolol by beta 2-adrenergic lymphocytic receptors in essential hypertension].
    Prikryl P; Kunovská V; Rysánek K; Vondrácek V; Prásek J
    Cas Lek Cesk; 1986 Apr; 125(16):481-4. PubMed ID: 3013406
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of aging on neurotransmitter receptor binding in rat and human brain.
    Maggi A; Schmidt MJ; Ghetti B; Enna SJ
    Life Sci; 1979 Jan; 24(4):367-73. PubMed ID: 34766
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of (-)-[3H]dihydroalprenolol to study beta adrenergic receptor-adenylate cyclase coupling in C6 glioma cells: role of 5'-guanylylimidodiphosphate.
    Lucas M; Bockaert J
    Mol Pharmacol; 1977 Mar; 13(2):314-29. PubMed ID: 192993
    [No Abstract]   [Full Text] [Related]  

  • 18. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
    Vauquelin G; Bottari S; Strosberg AD
    Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
    [No Abstract]   [Full Text] [Related]  

  • 19. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
    Baker SP; Pitha J
    J Pharmacol Exp Ther; 1982 Feb; 220(2):247-51. PubMed ID: 6120224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of an endogenous, competitive inhibitor(s) of [3H] diazepam binding in bovine brain.
    Marangos PJ; Paul SM; Greenlaw P; Goodwin FK; Skolnick P
    Life Sci; 1978 Jun; 22(21):1893-900. PubMed ID: 209277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.